Comments
FDA panel endorses drug for age-related eye problem
27.07.2012. | WASHINGTON (Reuters) - A Food and Drug Administration panel on Thursday recommended ThromboGenics NV's ocriplasmin as a treatment for vitreomacular adhesion, an aging-related vision problem that can lead to blindness....
